Guangdong Biolight Meditech Co Ltd
SZSE:300246
Intrinsic Value
Guangdong Biolight Meditech Co., Ltd. engages in the research, development, production, sale, and service of medical device products. [ Read More ]
The intrinsic value of one Guangdong Biolight Meditech Co Ltd stock under the Base Case scenario is 12.51 CNY. Compared to the current market price of 6.55 CNY, Guangdong Biolight Meditech Co Ltd is Undervalued by 48%.
Valuation Backtest
Guangdong Biolight Meditech Co Ltd
Run backtest to discover the historical profit from buying and selling Guangdong Biolight Meditech Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Guangdong Biolight Meditech Co Ltd
| Current Assets | 1.4B |
| Cash & Short-Term Investments | 755.7m |
| Receivables | 340.7m |
| Other Current Assets | 309.9m |
| Non-Current Assets | 1.2B |
| Long-Term Investments | 26.3m |
| PP&E | 833.3m |
| Intangibles | 233.9m |
| Other Non-Current Assets | 118.1m |
| Current Liabilities | 704.3m |
| Accounts Payable | 203.2m |
| Accrued Liabilities | 21.4m |
| Short-Term Debt | 263.3m |
| Other Current Liabilities | 216.4m |
| Non-Current Liabilities | 469.2m |
| Long-Term Debt | 323.4m |
| Other Non-Current Liabilities | 145.8m |
Earnings Waterfall
Guangdong Biolight Meditech Co Ltd
|
Revenue
|
1.3B
CNY
|
|
Cost of Revenue
|
-860m
CNY
|
|
Gross Profit
|
407.3m
CNY
|
|
Operating Expenses
|
-318.7m
CNY
|
|
Operating Income
|
88.6m
CNY
|
|
Other Expenses
|
-12.6m
CNY
|
|
Net Income
|
76.1m
CNY
|
Free Cash Flow Analysis
Guangdong Biolight Meditech Co Ltd
Profitability Score
Profitability Due Diligence
Guangdong Biolight Meditech Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Guangdong Biolight Meditech Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Guangdong Biolight Meditech Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Score
Guangdong Biolight Meditech Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Guangdong Biolight Meditech Co Ltd
According to Wall Street analysts, the average 1-year price target for Guangdong Biolight Meditech Co Ltd is 25 CNY .
Shareholder Return
Price
Guangdong Biolight Meditech Co Ltd
| Average Annual Return | 10.33% |
| Standard Deviation of Annual Returns | 43.45% |
| Max Drawdown | -82% |
| Market Capitalization | 1.7B CNY |
| Shares Outstanding | 264 575 008 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Guangdong Biolight Meditech Co., Ltd. engages in the research, development, production, sale, and service of medical device products. The company is headquartered in Zhuhai, Guangdong and currently employs 1,335 full-time employees. The company went IPO on 2011-07-19. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The firm distributes its products in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Guangdong Biolight Meditech Co Ltd stock under the Base Case scenario is 12.51 CNY.
Compared to the current market price of 6.55 CNY, Guangdong Biolight Meditech Co Ltd is Undervalued by 48%.
You don't have any saved screeners yet
